200
Participants
Start Date
December 31, 2013
Primary Completion Date
April 30, 2016
Study Completion Date
September 30, 2016
Atorvastatin
20 mg (every evening orally) for 8 weeks
placebo
20 mg (every evening orally) for 8 weeks
Tianjin Medical University General Hospital, Tianjin
Beijing tiantan hospital, Beijing
Chinese PLA General Hospital, Beijing
Peking union medical college hospital, Beijing
Cangzhou centerl hospital, Cangzhou
Xiangya hospital central southe university, Changsha
Southwest hospital, Chongqing
West china hospital, Chongqing
The first affiliated hospital of Fujian medical university, Fuzhou
Nanfang hospital, Guangzhou
First Affiliated Hospital of Harbin Medical University, Haerbing
Hainan general hospital, Haikou
117 Hospital of People's Liberation Army, Hangzhou
The second Affiliated hospital of zhejiang university school of medicine, Hangzhou
Anhui provincial hospital, Hefei
Inner mongolia people's hospital, Hohehot
Qilu hospital of shandong university, Jinan
Linyi People's Hospital, Linyi
Jiangsu province hospital, Nanjing
Ordos Central Hospital, Ordos
Changzheng Hospital, Shanghai
Huashan hospital, Shanghai
The second hospital of Hebei medical university, Shijiazhuang
The first hospital of Shanxi medical university, Taiyuan
Tongji hospital, Wuhan
Tangdu hospital, Xi'an
Xijing Hospital, Xi'an
Prince of Wales Hospital, Xianggang
The Affiliated Hospital of Xuzhou Medical College, Xuzhou
General Hospital of Ningxia Medical University, Yinchuan
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Oriental Neurosurgery Evidence-Based-Study Team
OTHER